期刊文献+

大剂量乌司他丁对大面积烧伤患者凝血功能的影响及意义 被引量:7

The influence of high dose ulinastatin on blood coagulation function in severely burned patients and its significance
下载PDF
导出
摘要 目的:观察大剂量乌司他丁对大面积烧伤患者凝血功能的影响。方法:4例大面积烧伤患者入院后第3天起每天给予大剂量乌司他丁(60万U,4次/d),用药前及用药后1d、3d、7d、10d、14d,抽血观察血浆纤维蛋白原含量(Fib-c)、凝血酶原时间(PT)、凝血酶时间(TT)、部分凝血活酶时间(APTT)及血浆D-二聚体含量的变化。结果:用药前血浆D-二聚体及纤维蛋白原含量明显升高,PT时间显著延长;给予大剂量乌司他丁1d后,血浆D-二聚体及纤维蛋白原含量明显减低,PT时间迅速恢复。结论:大面积烧伤患者早期应用大剂量乌司他丁可显著改善凝血功能,预防播散性血管内凝血的发生。 Objective:To observe the influence of high dose ulinastatin on blood coagulation function in severely burned patients.Methods:Four patients were enrolled in this study,high dose ulinastatin (600,000U,q.i.d) was given intravenously after admission,the changes in PT,APTT,TT,and levels of fibrinogen as well as D-dimer were measured before and after treatment on days 1,3,5,7,9,and 11.Results:The levels of fibrinogen and D-di- mer.were dramatically high before treatment,and they were decreased rapidly on day 1 after treatment,the values of PT were also recovered on day 1 after treatment Conclusion:High dose ulinastatin can dramatically ameliorate blood coagulation disorder in early stage of severely burned patients,and prevent the development of disseminated introvascular coagulation (DIC).
机构地区 解放军总医院
出处 《感染.炎症.修复》 2005年第3期162-164,共3页 Infection Inflammation Repair
关键词 乌司他丁 重症烧伤 凝血功能 Ulinastatin Severe burn Blood coagulation
  • 相关文献

参考文献6

二级参考文献19

  • 1丛玉隆 王鸿利 王学锋 主编.血栓病的诊断[A].王鸿利,王学锋,主编.血栓病临床新技术[C].北京: 人民军医出版社,2003.116-124.
  • 2宋善俊 沈迪 凌柱三 主编.弥散性血管内凝血[A].沈迪,凌柱三,主编.临床出血病学[C].上海:科学技术文献出版社,1996.416-422.
  • 3Kessler C,Blood,1997年,89卷,4393页
  • 4Creasey A A,J Clin Invest,1993年,91卷,2850页
  • 5Bone RC, Balk RA,Cerra FB, et al.American college of chest physicians/society of critical care medicine consensus conferences:Definitions for sepsis and organ failure and guideline for the use of innovative therapies in sepsis[J]. Chest. 1992,101:1644~ 1655
  • 6Glauser MP:Pathophysiologic basis of sepsis:Consideration for future strategies of intervention[J]. Crit Care Med.2000,28(9):4~ 8
  • 7Doshi SN,Marmur JD: Evolving role of tissue factor and its pathway inhibitor[J]. Crit Care Med.2002,30(5):241~ 250
  • 8Hack CE:Tissue factor pathway of coagulation in sepsis[J].Crit Care Med.2000,28(9):25~ 30
  • 9Uchida M, Okajima K, Murakami K, et al: Effects of various doses of antithrombin Ⅲ on endotoxin induced endothelial cell injury and coagulation abnormalities in rats[J]. Thromb Res.1998,89:233~ 241
  • 10Opal SM:Therapeutic rationale for antithrombin III in sepsis[J].Crit Care Med.2000.28(9):34~ 37

共引文献384

同被引文献87

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部